Inventor profile of:

XIAOLING LI

City:

DUBLIN, California

Country:

United States

Published Applications:

44

Last publication date:

2025-11-27

Top Assignees for applications by XIAOLING LI

The entities that hold a legal rights for patent applications filed by inventor LI XIAOLING:

Recent patent applications by LI XIAOLING

XIAOLING LI from DUBLIN, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-27
US20250360081A1
Human necessities

ORAL DRUG DOSAGE FORMS FOR STOMACH RETENTION

#2 | 2025-10-02
US20250303640A1
Performing operations; transporting

HIGH-THROUGHPUT AND HIGH-PRECISION PHARMACEUTICAL ADDITIVE MANUFACTURING SYSTEM

#3 | 2025-08-21
US20250262164A1
Human necessities

ORAL DRUG DOSAGE FORMS HAVING A DESIRED PK PROFILE AND METHODS OF DESIGNING AND PRODUCING THEREOF

#4 | 2025-02-13
US20250049723A1
Human necessities

PRECISION PHARMACEUTICAL 3D PRINTING DEVICE

#5 | 2025-02-06
US20250042589A1
Performing operations; transporting

CONTINUOUS UNLOADING AND PACKAGING SYSTEM OF PHARMACEUTICAL ADDITIVE MANUFACTURING

#6 | 2024-12-12
US20240408023A1
Human necessities

DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES

#7 | 2024-10-17
US20240342094A1
Human necessities

COMPARTMENTED PHARMACEUTICAL DOSAGE FORMS

#8 | 2024-09-26
US20240316864A1
Performing operations; transporting

HIGH-PRECISION ADDITIVE MANUFACTURING DEVICE AND HIGH-THROUGHPUT ADDITIVE MANUFACTURING SYSTEM

#9 | 2024-06-06
US20240180840A1
Human necessities

METHODS OF DESIGNING AN ORAL DRUG DOSAGE FORM BASED ON A TARGET PK PROFILE AND DOSAGE FORMS THEREOF

#10 | 2024-02-08
US20240041779A1
Human necessities

DELAYED SUSTAINED-RELEASE ORAL DRUG DOSAGE FORMS OF A JANUS KINASE (JAK) INHIBITOR AND METHODS OF USE

#11 | 2023-12-14
US20230398066A1
Human necessities

DRUG DOSAGE FORMS FOR STOMACH RETENTION

#12 | 2023-12-07
US20230390193A1
Human necessities

GASTRORETENTIVE PHARMACEUTICAL DOSAGE FORM

#13 | 2023-07-20
US20230225978A1
Human necessities

Precision pharmaceutical 3D printing device

#14 | 2023-03-09
US20230070928A1
Performing operations; transporting

Continuous unloading and packaging system of pharmaceutical additive manufacturing

#15 | 2023-02-16
US20230048362A1
Performing operations; transporting

HIGH-THROUGHPUT AND HIGH-PRECISION PHARMACEUTICAL ADDITIVE MANUFACTURING SYSTEM

#16 | 2022-10-27
US20220339857A1
Performing operations; transporting

3D PRINTING DEVICE AND METHOD

#17 | 2022-07-07
US20220212408A1
Performing operations; transporting

High-throughput and high-precision pharmaceutical additive manufacturing system

#18 | 2022-07-07
US20220212404A1
Performing operations; transporting

High-throughput and high-precision pharmaceutical additive manufacturing system

#19 | 2022-04-21
US20220118698A1
Performing operations; transporting

High-precision additive manufacturing device and high-throughput additive manufacturing system

#20 | 2021-07-08
US20210205226A1
Human necessities

ORAL DRUG DOSAGE FORM COMPRISING DRUG IN THE FORM OF NANOPARTICLES

#21 | 2021-07-01
US20210196638A1
Human necessities

ORAL DRUG DOSAGE FORMS HAVING A DESIRED PK PROFILE AND METHODS OF DESIGNING AND PRODUCING THEREOF

#22 | 2021-06-17
US20210178677A1
Performing operations; transporting

High-throughput and high-precision pharmaceutical additive manufacturing system

#23 | 2021-05-27
US20210154910A1
Performing operations; transporting

3D printing device and method

#24 | 2021-05-06
US20210128479A1
Human necessities

Dosage forms of controlled release at specific gastrointestinal sites

#25 | 2021-03-18
US20210078244A1
Performing operations; transporting

DOSAGE FORMS WITH DESIRED RELEASE PROFILES AND METHODS OF DESIGNING AND MAKING THEREOF

#26 | 2021-03-18
US20210077410A1
Human necessities

Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant

#27 | 2020-12-10
US20200384117A1
Human necessities

Enhanced SN-38 anticancer agent

#28 | 2020-10-29
US20200338009A1
Human necessities

Precision pharmaceutical 3D printing device

#29 | 2020-10-08
US20200315971A1
Human necessities

3D printing methods for compartmented pharmaceutical dosage forms

#30 | 2020-06-11
US20200179525A1
Human necessities

Enhanced anticancer agent

#31 | 2019-12-05
US20190365912A1
Human necessities

Delivering enhanced active agents

#32 | 2019-10-24
US20190321299A1
Human necessities

Oral drug dosage form comprising various release profiles

#33 | 2019-07-11
US20190209482A1
Human necessities

Precision pharmaceutical 3D printing device

#34 | 2019-07-11
US20190209468A1
Human necessities

Dosage forms with desired release profiles and methods of designing and making thereof

#35 | 2019-06-27
US20190192440A1
Human necessities

Oral drug dosage form comprising drug in the form of nanoparticles

#36 | 2019-03-14
US20190076546A1
Human necessities

Enhanced active agents

#37 | 2019-02-12
US15937528
Human necessities

Precision pharmaceutical 3D printing device

#38 | 2018-11-01
US20180311167A1
Human necessities

Oral drug dosage forms having desired drug release profiles and uses thereof

#39 | 2018-08-02
US20180215828A1
Chemistry; metallurgy

SYNTHETIC ANTIBODY MIMIC PEPTIDES

#40 | 2018-05-03
US20180116911A1
Human necessities

Controlled release dosage form

#41 | 2018-01-25
US20180021446A1
Human necessities

Systems for stabilizing and delivering active agents

#42 | 2017-04-13
US20170101474A1
Chemistry; metallurgy

Synthetic antibody mimic peptides

#43 | 2016-12-08
US20160354315A1
Human necessities

Compartmented pharmaceutical dosage forms

#44 | 2016-02-18
US20160045609A1
Human necessities

CONJUGATION OF PHARMACEUTICALLY ACTIVE AGENTS WITH TRANSTHYRETIN LIGANDS THROUGH ADJUSTABLE LINKERS TO INCREASE SERUM HALF-LIFE

InventorID:

1443897 ⎘